9-136429827-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019892.6(INPP5E):​c.1803-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,610,946 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 3 hom. )

Consequence

INPP5E
NM_019892.6 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.477

Publications

1 publications found
Variant links:
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
  • Joubert syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • MORM syndrome
    Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 9-136429827-G-A is Benign according to our data. Variant chr9-136429827-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 261201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00106 (1552/1459088) while in subpopulation NFE AF = 0.00129 (1429/1111002). AF 95% confidence interval is 0.00123. There are 3 homozygotes in GnomAdExome4. There are 717 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INPP5ENM_019892.6 linkc.1803-20C>T intron_variant Intron 9 of 9 ENST00000371712.4 NP_063945.2 Q9NRR6-1
INPP5ENM_001318502.2 linkc.1800-20C>T intron_variant Intron 9 of 9 NP_001305431.1 Q9NRR6
INPP5EXM_017014926.2 linkc.1803-67C>T intron_variant Intron 9 of 9 XP_016870415.1
INPP5EXM_047423603.1 linkc.1800-67C>T intron_variant Intron 9 of 9 XP_047279559.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INPP5EENST00000371712.4 linkc.1803-20C>T intron_variant Intron 9 of 9 1 NM_019892.6 ENSP00000360777.3 Q9NRR6-1
INPP5EENST00000676019.1 linkc.1701-20C>T intron_variant Intron 9 of 9 ENSP00000501984.1 Q9NRR6-2

Frequencies

GnomAD3 genomes
AF:
0.000540
AC:
82
AN:
151740
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000972
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000402
AC:
100
AN:
249046
AF XY:
0.000348
show subpopulations
Gnomad AFR exome
AF:
0.000125
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.0000999
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000774
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.00106
AC:
1552
AN:
1459088
Hom.:
3
Cov.:
33
AF XY:
0.000988
AC XY:
717
AN XY:
725884
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33424
American (AMR)
AF:
0.000224
AC:
10
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26090
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52432
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5362
European-Non Finnish (NFE)
AF:
0.00129
AC:
1429
AN:
1111002
Other (OTH)
AF:
0.00168
AC:
101
AN:
60270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
78
155
233
310
388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000540
AC:
82
AN:
151858
Hom.:
0
Cov.:
32
AF XY:
0.000431
AC XY:
32
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41414
American (AMR)
AF:
0.000262
AC:
4
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10560
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000972
AC:
66
AN:
67882
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000990
Hom.:
0
Bravo
AF:
0.000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 23, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.068
DANN
Benign
0.49
PhyloP100
-0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190316580; hg19: chr9-139324279; API